secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANGIODYNAMICS INC (ANGO)
CIK:        0001275187
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001140361-23-028985
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AngioDynamics sells dialysis product portfolio and BioSentry to Merit Medical for $100M cash
--------------------------------------------------------------------------------

- Deal includes DuraFlow, DuraMax, Evenmore, Schon XL, Trio-CT, Vaxel Plus catheters and BioSentry biopsy product.
- Divested portfolio contributed approximately $32M in sales in FY2023.
- Net proceeds will be used to eliminate existing debt and fund strategic growth investments.
- Transaction is dilutive to adjusted EPS and slightly dilutive to corporate gross margins.
- Preliminary FY2023 net sales in the range of $338M to $339M; full results due early July.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1275187/000114036123028985/0001140361-23-028985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1275187/000114036123028985/brhc20054227_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-028985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer